Losartan and Fetzima drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Losartan (losartan potassium) and Fetzima (levomilnacipran hydrochloride). Common drug interactions include infusion site erythema among females and back disorder among males.
The phase IV clinical study analyzes what interactions people have when they take Losartan and Fetzima. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.
What is Losartan?
Losartan has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 177,695 Losartan users. Check the latest studies of Losartan.
What is Fetzima?
Fetzima has active ingredients of levomilnacipran hydrochloride. It is often used in depression. eHealthMe is studying from 2,077 Fetzima users. Check the latest studies of Fetzima.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
46 people who take Losartan and Fetzima together, and have interactions are studied.

What are the common drug interactions of Losartan and Fetzima, by gender? *:
female:
- Infusion site erythema (reddening of the skin at infusion site)
- Infusion site pruritus (severe itching at infusion site)
- Infusion site swelling
- Malaise (a feeling of general discomfort or uneasiness)
- Middle ear effusion (fluid in middle ear)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Neuropathy peripheral (surface nerve damage)
- Organ failure
- Oropharyngeal pain
- Panic attack
male:
- Back disorder
- Rash
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Emotional distress
- Fatigue (feeling of tiredness)
- Gait disturbance
- Insomnia (sleeplessness)
- Ligament sprain (ligament stretched)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
What are the common drug interactions of Losartan and Fetzima, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Back disorder
- Rash
- Road traffic accident
- Anxiety
- Neuralgia (pain in one or more nerves)
- Vertebral foraminal stenosis (narrowing of the intervertebral foramen)
- Accident at work
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Emotional distress
- Fatigue (feeling of tiredness)
60+:
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
- Confusional state
- Psoriasis (immune-mediated disease that affects the skin)
- Vitamin d deficiency
- Wound infection
- Abnormal dreams
- Arrhythmia (irregular heartbeat)
- Agitation (state of anxiety or nervous excitement)
- Anxiety
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 16 people, 34.78%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 21.74%
- Insomnia (sleeplessness): 7 people, 15.22%
- Immunodeficiency Common Variable: 4 people, 8.70%
- Stress And Anxiety: 3 people, 6.52%
- Pain: 3 people, 6.52%
* Approximation only. Some reports may have incomplete information.
Do you take Losartan and Fetzima?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Losartan and Fetzima:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Losartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Fetzima:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Losartan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Fetzima and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
- Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on losartan potassium and levomilnacipran hydrochloride (the active ingredients of Losartan and Fetzima, respectively), and Losartan and Fetzima (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Terbinafine Hydrochloride cause Ageusia? - 5 seconds ago
- Could Glycolax cause Glaucoma? - 5 seconds ago
- Could Cipro cause Gallbladder Polyp? - 8 seconds ago
- Lipids Abnormal and Red Blood Cell Sedimentation Rate Increased - 8 seconds ago
- Drug interactions of Clonazepam and Valeriana Officinalis - 8 seconds ago
- Could Lamotrigine cause Enterocolitis? - 11 seconds ago
- Could Lanoxin cause Prothrombin Level Decreased? - 11 seconds ago
- Could Allopurinol cause Oesophageal Polyp? - 14 seconds ago
- Could Erbitux cause Ascites? - 19 seconds ago
- Could Oxaliplatin cause Drowsiness? - 33 seconds ago